Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptide epoxyketone proteasome inhibitors in combination with PIM kinase inhibitors for treatment of cancers

Peptide epoxyketone proteasome inhibitors in combination with PIM kinase inhibitors for treatment of cancers

US Patent 12076363 · Granted Sep 3, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunoglobulin expression levels as biomarker for proteasome inhibitor response2020
Combination therapy with peptide epoxyketones2020
Anchoring apparatus for bedclothes2020
Combination therapy with peptide epoxyketones2020
Liposomal compositions of epoxyketone-based proteasome inhibitors2018
Combination therapy with peptide epoxyketones2016
Modified release formulations for oprozomib2016
Use of peptide epoxyketones for metastasis suppression2014
Nitrous oxide plate system for engines2003
Position finding system1987